Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services (1)
Select solutions (2)
Active Filters (3)
Clear All
1 - 12 of 31 Results
Sort by:
Best Match

Applying functional genomics strategies to high-content phenotypic screening
Explore cutting-edge functional genomics and high-content phenotypic screening in drug discovery. Download our whitepaper to learn about innovative techniques, best practices, and strategies for leveraging high-content imaging methods like cell painting to advance your research. Unlock the potential of genomic profiling and morphological analysis for therapeutic interventions

Nonalcoholic fatty liver disease (NAFLD)
Explore this infographic on NAFLD, including facts on epidemiology and risk factors, development, and disease progression.

Reagent solutions for virology research
Discovery a range of immunoassays and other products Revvity offers to help you save time, increase your productivity in virology research.

Recent advances in targeted protein degradation research in cancer.
Explore groundbreaking cancer therapy with our TPD literature review, featuring advanced no-wash immunoassays and the latest research on PROTACs and molecular glues.

Advancing autophagy detection: HTRF LC3B-II assay for specific and reliable LC3B-II detection
This study validates the HTRF LC3B-II immunoassay as a reliable, precise, and faster alternative to the traditional LC3 Western Blot for quantifying autophagy in various cellular models.

Modulation of Bcl-2 Expression in MCF7 Cells Using LANCE TR-FRET Technology
This study demonstrates the effectiveness of LANCE Ultra TR-FRET assay technology in identifying and characterizing Bcl-2 protein expression in MCF7 cells, with expression levels modulated by agents that induce cell death and affect proliferation. The assay’s versatility is further highlighted by its application to suspension cell lines and frozen cellular lysates.

STING, the next candidate for cancer immunotherapy
Discover an introduction to STING in this infographic. Targeting the STING pathway is a strong candidate for cancer therapy, so jumpstart your knowledge here!

Reagent solutions for autoimmunity research
Combat autoimmune diseases efficiently with our reagent technologies. Explore a broad biochemical portfolio targeting inflammation pathways.

Unlocking insights with AlphaLISA anti-drug antibodies detection assays
Unlock ADA insights with AlphaLISA technology.

Accelerating immuno-oncology therapeutic development: choosing the best preclinical model
Selecting the appropriate preclinical model for immuno-oncology therapeutic development.

Eyes on synaptotagmin 7 (SYT7) in synaptic function and neuroplastic health for cognitive decline
Researcher, Dr. Jason Vevea, describes the role of synaptotogmin 7 in the synaptic vesicle cycle and the experimental steps taken to discover that SYT7 supports asynchronous release, short-term synaptic plasticity, and synaptic vesicle replenishment.

Antibody-based therapeutic modalities in oncology
Explore monoclonal antibody-based cancer therapeutics in this white paper, covering mechanism of action, development, and challenges.


Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.